Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients. - Wikidata - wikimedia - TriplyDB

Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.

Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.

http://www.wikidata.org/entity/Q36523671

about

Stem cells, colorectal cancer and cancer stem cell markers correlations CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives Association between NQO1 C609T polymorphism and prostate cancer risk Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma Prognostic role of CD133 expression in colorectal cancer: a meta-analysis Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients.Prognostic value of stem cell quantification in stage II colon cancer.Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis.Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis.Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma.CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis Prognostic significance of B7-H3 expression in patients with colorectal cancer: A meta-analysis.Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer.SOX10 is a novel oncogene in hepatocellular carcinoma through Wnt/β-catenin/TCF4 cascade.Combinatorial immunotherapy of sorafenib and blockade of programmed death-ligand 1 induces effective natural killer cell responses against hepatocellular carcinoma.Prognostic significance of CD133 and ezrin expression in colorectal carcinoma.Association between IL-4 -589C>T polymorphism and colorectal cancer risk.Oncogenicity of the transcription factor SOX8 in hepatocellular carcinoma.Immunopathological characterization of cryptoglandular anal fistula: a pilot study investigating its pathogenesis.Association between estrogen receptor alpha PvuII polymorphism and prostate cancer risk.CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies.Colonic Stem Cells Expression of Lgr5 and CD133 Proteins as Predictive Markers in Colorectal Cancer among Egyptian Patients.

P2860

Q26823217-B186F377-377B-4657-A00E-17A714A46253 Q26827628-AEC4664B-7920-4320-BBC6-9B63C5683C65 Q27024651-A9B845B2-16D1-4DCE-9EB9-9D31318CD042 Q28240340-D172570C-3906-4AC1-BFF9-C6A9454AF29E Q34486212-4ADCA60E-F85C-4A05-9D23-7EEA8128CE53 Q34502600-4831310E-031B-460A-A190-9EBF8624DE41 Q34984086-0F64F886-A5EF-4BC7-A5E7-2186A41E2D5D Q35106095-9743737B-77AE-4289-843F-5F5A09918783 Q35833372-6CEAE38E-92C3-484C-875F-8D73748BA018 Q35870637-E669600D-7CCC-46D5-9900-80C8B42CE120 Q35899912-AC6C4440-1A62-462D-A459-34FCA7EDB79C Q36962860-AB6EB55A-EF1B-4C54-991E-A21BEACCC89B Q37563260-455A65CF-E183-41B8-8987-66E329736F8B Q38163598-255E174B-3923-4BF2-A6CB-4B3D932B56FF Q38977452-CC0E5F72-63F8-4B33-8412-2B8FB2B1ED2F Q41676912-079F6382-24B6-4DBF-BB91-A359680E7A50 Q46403034-6A04DC52-B89C-446D-B539-0C010F9E45EB Q46735674-284FD72D-6FDE-4747-B426-3A7D2A818E24 Q50676592-D58068B4-3AA4-4C12-9B2F-B1EC37B03935 Q51484243-BA23A4B5-D01F-485F-BFEE-60D0BE81A725 Q53134069-A99628C0-4070-4D38-8116-2BD017261E8E Q55285304-08FBA3C4-2800-4B48-80FC-493B379D2370 Q55516194-B3A16AD3-B843-4B22-AB59-2D04700C01A2

P2860

Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.

http://www.wikidata.org/entity/Q36523671

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Increased expression of CD133 ...... come in colon cancer patients.

@ast

Increased expression of CD133 ...... come in colon cancer patients.

@en

type

label

Increased expression of CD133 ...... come in colon cancer patients.

@ast

Increased expression of CD133 ...... come in colon cancer patients.

@en

prefLabel

Increased expression of CD133 ...... come in colon cancer patients.

@ast

Increased expression of CD133 ...... come in colon cancer patients.

@en

P1433

Q36523671-7F7CF861-383B-4EC5-8B7E-1D05D754D649

P1476

Q36523671-01DF6773-C5E3-479F-99E5-BECFFBF76FCE

P2093

Q36523671-110E14C3-118B-4AFD-866A-64C31DFBC593

Q36523671-4668176D-541A-4084-9A4D-7D27B407B6D5

Q36523671-673879E0-1C46-4354-9E3F-87DF814B857E

Q36523671-711825C4-1174-4EEA-8C8D-5B9791639CBC

Q36523671-82A3D314-C4B5-4A32-9315-3F306AC5C957

Q36523671-8AB09FC9-155A-4C3D-A1AE-9B178CD54228

Q36523671-8C297B12-81D4-416B-BCE7-D348744CD16E

Q36523671-AEB2AFD5-F182-46E5-A610-9B4F2D02420B

Q36523671-B92A62FE-507F-4577-A9A2-FA50822FC865

Q36523671-CA79B7BB-AD2F-4BA1-AE4D-F94E90403B38

P2860

Q36523671-098E8BA6-6A9C-4F0F-9130-DE88319C7134

Q36523671-0EAF6FC0-89C1-4064-8409-8A530CDE127D

Q36523671-0F04FA37-37EB-4BA6-A9DE-B5AEC5F93A9D

Q36523671-1576B3EB-0414-4AC7-9E93-1D126248A901

Q36523671-19C2A7A2-6D57-4B52-9B9D-55063C3BEE18

Q36523671-1EE4A649-EDC8-429A-8DA2-ED7274C1A9EA

Q36523671-3436C114-EA81-45CC-84F5-1EAAD9AA2806

Q36523671-346B93D9-1A17-4385-8DBE-6F2CD40F0B5E

Q36523671-349266C6-E05D-4FEE-88E5-4C9E6E3AF1DA

Q36523671-3DD86E11-9064-4406-9FE1-5DDF7135501A

P2888

Q36523671-B792B912-AFDD-4813-9961-0083459E7677

P304

Q36523671-9EF9C76B-102B-4FF5-9B3B-5D38546F09CB

P31

Q36523671-4093A53F-725A-4F71-8C7B-0720ACF2EF37

P356

Q36523671-2CFFC0FD-402F-4215-AD45-D3041A194EFC

P478

Q36523671-298F0D59-8718-460E-A070-A3CB48294A7D

P50

Q36523671-12CEB264-64FE-4916-8B8E-E19064DF3763

P577

Q36523671-1FB5D4D5-A1C5-4E5A-89F2-69634D6207B6

P5875

Q36523671-F18B532E-C1BA-4F1F-A7C7-7506C36A8F5E

P6179

Q36523671-DE676772-CD5F-433D-A366-A8A1C4E8B43B

P698

Q36523671-39A18DA4-F4EF-4E3B-96F4-E332641B85F4

P932

Q36523671-8AF23B9C-1337-4019-9F15-B10A336EB367

P356

1756-9966-31-71

P1433

Journal of Experimental & Clinical Cancer Research

P1476

Increased expression of CD133 ...... tcome in colon cancer patients

@en

P2093

Achille Cittadini

http://www.w3.org/2001/XMLSchema#string

Alma Boninsegna

http://www.w3.org/2001/XMLSchema#string

Claudio Coco

http://www.w3.org/2001/XMLSchema#string

Egidio Stigliano

http://www.w3.org/2001/XMLSchema#string

Emanuele Caredda

http://www.w3.org/2001/XMLSchema#string

Gian Franco Zannoni

http://www.w3.org/2001/XMLSchema#string

Gianluca Rizzo

http://www.w3.org/2001/XMLSchema#string

Giannicola Genovese

http://www.w3.org/2001/XMLSchema#string

Luca Reggiani Bonetti

http://www.w3.org/2001/XMLSchema#string

Mario Migaldi

http://www.w3.org/2001/XMLSchema#string

P2860

Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

Identification and expansion of human colon-cancer-initiating cells

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer

CD133 gene overexpression is frequently observed in early colorectal carcinoma

The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation

More than markers: biological significance of cancer stem cell-defining molecules.

A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells.

The complexities of dystroglycan.

P2888

1756-9966-31-71

P304

71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-9966-31-71

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Sgambato

P577

2012-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230828674

http://www.w3.org/2001/XMLSchema#string

P6179

1017345355

http://www.w3.org/2001/XMLSchema#string

P698

22964035

http://www.w3.org/2001/XMLSchema#string

P932

3541988

http://www.w3.org/2001/XMLSchema#string